Effectiveness of milnacipran for the treatment of chronic pain in the orofacial region

Clinical Neuropharmacology

Volumn 33, Issue 2, 2010, Pages 79-83

  Ito, Mikiko ^a   Kimura, Hiroyuki ^b   Yoshida, Keizo ^c   Kimura, Yuki ^a   Ozaki, Norio ^b   Kurita, Kenichi ^a  

^a AICHI GAKUIN UNIVERSITY   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c DENSO CORPORATION   (Japan)

Author keywords

Atypical odontalgia; Burning mouth syndrome; Chronic pain; Milnacipran; Serotonin norepinephrine reuptake inhibitor

Indexed keywords

ALPRAZOLAM; BROTIZOLAM; MILNACIPRAN;

ADULT; ARTICLE; ATYPICAL ODONTALGIA; BURNING MOUTH SYNDROME; CHRONIC PAIN; CONSTIPATION; DEPRESSION; DRUG DOSE INCREASE; DRUG EFFICACY; FEMALE; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; PAIN ASSESSMENT; PRIORITY JOURNAL; TOOTH PAIN; VISUAL ANALOG SCALE;

ADRENERGIC UPTAKE INHIBITORS; ADULT; AGED; BURNING MOUTH SYNDROME; CHRONIC DISEASE; CYCLOPROPANES; DEPRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; FACIAL PAIN; FEMALE; HUMANS; MALE; MIDDLE AGED; SEROTONIN UPTAKE INHIBITORS; TOOTHACHE;

EID: 77951032561     PISSN: 03625664     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNF.0b013e3181cb5793     Document Type: Article

References (24)

1. Engman MF. Burning tongue. Arch Dermatol Syph 1920;1:137-138.
2. Melis M, Lobo SL, Cenevis C, et al. Atypical odontalgia: a review of the literature. Headache 2003;43:1060-1074.
3. McElin TW, Horton BT. Atypical face pain. A statistical consideration of 66 cases. Ann Intern Med 1947;27:749-768.
4. Scala A, Checchi L, Montevecchi M, et al. Update on burning mouth syndrome: overview and patient management. Crit Rev Oral Biol Med 2003;14:275-291.
5. Speciali JG, Stuginski-Barbosa J. Burning mouth syndrome. Curr Pain Headache Rep 2008;12:279-284.
6. Baad-Hansen L. Atypical odontalgia-pathophysiology and clinical management. J Oral Rehabil 2008;35:1-11.
7. Ansari A. The efficacy of newer antidepressants in the treatment of chronic pain: a review of current literature. Harv Rev Psychiatry 2000;7:257-277.
8. Mico JA, Ardid D, Berrocoso E, et al. Antidepressants and pain. Trends Pharmacol Sci 2006;27:348-354.
9. Lynch ME. Antidepressants as analgesics: a review of randomized controlled trials. J Psychiatry Neurosci 2001;26:30-36.
10. Vitton O, Gendreau M, Gendreau J, et al. A double-blind placebo-controlled trial of milnacipran in the treatment of fibromyalgia. Hum Psychopharmacol 2004;19:27-35.
11. Gendreau RM, Thorn MD, Gendreau JF, et al. Efficacy of milnacipran in patients with fibromyalgia. J Rheumatol 2005;32:1975-1985.
12. Kamata M, Takahashi H, Naito S, et al. Effectiveness of milnacipran for the treatment of chronic pain: a case series. Clin Neuropharmacol 2004;27:208-210
13. Toyofuku A. Efficacy of milnacipran for glossodynia patients. Int J Psychiatry Clin Pract 2003;7:23-24.
14. Shimamoto E, Doi N, Suwa H, et al. A case of postherpetic neuralgia improved by milnacipran. Jpn J Clin Psychopharmacol 2002;5:197-200.
15. Utunomiya K, Ukita T, Hirita S. One case of postherpetic neuralgia treated with milnacipran. Jpn J Clin Psychopharmacol 2002;5:193-196.
16. Ito M, Yoshida K, Kimura H, et al. Successful treatment of trigeminal neuralgia with milnacipran. Clin Neuropharmacol 2007;30:183-185.
17. Ito M, Kondo M, Ito T, et al. A trial of team approach based on liaison psychiatry in the division of psychosomatic dentistry [abstract]. The 9th Asian Chapter of the International College of Psychosomatic Medicine, Tokyo, Japan, 2000.
18. American Psychiatric Association. Diagnostic and Statistical Manual of Metal Disorders, Fourth Edition, Text Revision (DSM-IV-TR). Washington, DC: American Psychiatric Association; 2000.
19. Ikawa M, Yamada K, Ikeuchi S. Efficacy of amitriptyline for treatment of somatoform pain disorder in the orofacial region: a case series. J Orofac Pain 2006;3:234-240.
20. Basbaum AI, Fields HL. The origin of descending pathways in the dorsolateral funiculus of the spinal cord of the cat and rat: further studies on the anatomy of pain modulation. J Comp Neurol 1979;187:513-531.
21. Yokokawa F, Kiuchi Y, Ishikawa Y, et al. An investigation of monoamine receptors involved in antinociceptive effects of antidepressants. Anesth Analg 2002;95:163-168.
22. Stahl SM. Dose depression hurt? J Clin Psychiatr 2002;63:273-274.
23. Ohayon MM, Schatzberg AF. Using chronic pain to predict depressive morbidity in the general population. Arch Gen Psychiatry 2003;60:39-47.
24. Montogomery SA, Prost JF, Soles A, et al. Efficacy and tolerability of milnacipran: an overview. Int Clin Psychopharmacol 1996;11:47-51